Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Case Studies    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Case Studies
 
Fosun Pharma Wants to Be the Xiaomi of China's Drug Industry 9/10/2017
Ten Years and $100M+ Later, GSK Shutters a China R&D Site amid Re... 8/8/2017
BeyondSpring Pharma: Communicating Across US-China Lines 8/8/2017
GSK Sued by Couple It Hired to Investigate Whistleblower in 2013 3/14/2017
Backed by China, Ambrx No Longer Dependent on Partnerships with M... 11/2/2016
Aussie Entrepreneurs' Biotech Co Gets Demolished in China by Loca... 9/26/2016
Kobayashi Pharma: China Business Growth without China Presence 9/7/2016
Alibaba Health Re-engineers Business After Setbacks 7/9/2016
China's Bid To Be A DNA Superpower 6/22/2016
SciClone Pharmaceuticals: Building a Product Portfolio Optimized ... 7/2/2015
Birth of A New Novel Anticancer, Made in China 4/3/2015
A Decade Old Drug Launch in China with Important Insights Today 3/18/2015
Chinese Innovation: BGI's Code for Success 2/16/2015
Success Story: CleveXel's Collaboration with Guilin Pharma for De... 10/8/2014
RuiYi Raises US$15M to Amp Up Chinese R&D 3/28/2014
Why Did One Of The World's Largest Generic Drug Makers Exit China... 2/6/2014
How China's Biggest Biotech Company Cracked The U.S. Market 9/13/2013
With a Band of Biotech Collaborators, RuiYi Sets Sail Developing ... 5/16/2013
BGI: The Kung Fu Panda of The Genomic World (External) 4/18/2013
Pharmaceutical Company Loses CNY 1 Billion after 140-word Weibo M... 2/1/2013
Ipsen Outlines Strategies for Continued Growth in China - The Suc... 1/25/2013
Leveraging U.S. Resources and Chinese Partnership for Drug Develo... 11/7/2012
SciClone Pharma Rises on China Business Focus Despite R&D Drawbac... 3/16/2012
China Learns the Lesson of Vaccine R&D Bubble - The Story of Chon... 1/17/2012
Research Partnership between BMS and Simcere: The Right Chemistry... 1/9/2012
BeiGene Hopes to Clone Genentech's Success in China 7/7/2011
Case Study: Novo Nordisk China - Focusing on Diabetes (External) ... 10/26/2009
West Pharmaceutical Services - Tapping into China's growing healt... 9/23/2009
Case Study: Saridon Trademark Disputes between Roche/Bayer and So... 6/4/2009
HUYA Bioscience: Taping into China for novel drug candidates    1/8/2009
Page:1/2  Total number of articles:43  [1][2]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links